Moderna Submits Updated COVID-19 Vaccine to FDA Targeting LP.8.1 Variant Amid U.S. Surge #news

Moderna, Inc. $MRNA, a leading biotech firm and key player in the mRNA vaccine market, announced on Friday the submission of ...